/ /

  • linkedin
  • Increase Font
  • Sharebar

    Applying hydrogel technology to sustained-release ocular drugs

    Can be programmed for various disease states depending on molecule, duration of therapy

    Ophthalmic diseases present unique challenges to effective treatment. For instance, high degrees of physical dexterity and coordination are needed to apply ocular drops, which are sometimes uncomfortable once instilled and often expensive to purchase.

    Driscoll

    Treatments for the back of the eye require precise anatomic administration of an injection by a physician, which are frightening to patients, and frequency of these injections may include undesirable side effects and safety concerns.

    All of these factors create a substantial healthcare burden for patients, caregivers, and physicians, and frequently lead to poor compliance or discontinuation of treatment.

    Significant research and financial support has been dedicated to creating alternatives that will address these factors, and that will increase the quality of life and therapeutic effect in the ophthalmic realm.

     

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results